CENP-E inhibitor GSK-923295A
Term · Oncology and biomedicine · MLC-T-ONC-012513
A small-molecule inhibitor of the mitotic kinesin centromere-associated protein E (CENP-E), with potential antineoplastic activity. Upon administration, GSK-923295A binds to and inhibits CENP-E, thereby preventing cell division, inducing cell cycle arrest, and ultimately leading to an inhibition of cell proliferation. CENP-E, a kinetochore-associated mitotic kinesin, plays an essential role in chromosome movement during mitosis and regulates cell-cycle transition from metaphase to anaphase.
| Identifier | MLC-T-ONC-012513 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | centromere-associated protein E inhibitor GSK-923295 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012513",
"term": "CENP-E inhibitor GSK-923295A",
"field": "Oncology and biomedicine",
"definition": "A small-molecule inhibitor of the mitotic kinesin centromere-associated protein E (CENP-E), with potential antineoplastic activity. Upon administration, GSK-923295A binds to and inhibits CENP-E, thereby preventing cell division, inducing cell cycle arrest, and ultimately leading to an inhibition of cell proliferation. CENP-E, a kinetochore-associated mitotic kinesin, plays an essential role in chromosome movement during mitosis and regulates cell-cycle transition from metaphase to anaphase.",
"synonyms": [
"centromere-associated protein E inhibitor GSK-923295"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cenp-e-inhibitor-gsk-923295a/"
}
Record 4,579 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.